Results 191 to 200 of about 109,215 (254)
Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
American Journal of Clinical Pathology, 2016 L. Williams, M. Marques
semanticscholar +1 more source
Understanding thrombotic microangiopathies in children. [PDF]
Intensive Care Med, 2018 Joly BS, Zheng XL, Veyradier A.
europepmc +1 more source
Significance of complement system diagnostics in thrombotic microangiopathies [PDF]
, 2017 Csuka, Dorottya +4 more
core
Hemolytic uremic syndrome with Mycoplasma pneumoniae infection and membrane cofactor protein mutation [PDF]
, 2016 Csuka, Dorottya +5 more
core
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2003 C, Chiurchiu, G, Remuzzi
openaire +1 more source
Polish journal of pathology : official journal of the Polish Society of Pathologists, 2012 openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 2002
The thrombotic microangiopathies (TMA) are a group of diseases associated with microangiopathic hemolytic anemia, thrombocytopenia, and end-organ dysfunction. These seemingly disparate entities share in common a pathogenic mechanism involving endothelial injury and thrombus formation.
Joel L Moake
exaly +7 more sources
The thrombotic microangiopathies (TMA) are a group of diseases associated with microangiopathic hemolytic anemia, thrombocytopenia, and end-organ dysfunction. These seemingly disparate entities share in common a pathogenic mechanism involving endothelial injury and thrombus formation.
Joel L Moake
exaly +7 more sources
Emergency Medicine Clinics of North America
Thrombotic microangiopathies (TMAs) are rare diseases characterized by endothelial injury and microvascular clots. TMAs often lead to microangiopathic hemolytic anemia, thrombocytopenia, and end organ damage. Common TMA types include thrombotic thrombocytopenic purpura (TTP), infection-associated hemolytic uremic syndrome, and complement-mediated TMAs.
Ramy M Hanna, Ryan Gibney
exaly +3 more sources
Thrombotic microangiopathies (TMAs) are rare diseases characterized by endothelial injury and microvascular clots. TMAs often lead to microangiopathic hemolytic anemia, thrombocytopenia, and end organ damage. Common TMA types include thrombotic thrombocytopenic purpura (TTP), infection-associated hemolytic uremic syndrome, and complement-mediated TMAs.
Ramy M Hanna, Ryan Gibney
exaly +3 more sources